Equity Research, Broker Reports, and media content on Synairgen plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Synairgen plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Synairgen plc

Company Profile

  • Personnel
  • Richard J Marsden, CEO
  • John C Ward, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Synairgen plc. We currently have 92 research reports from 5 professional analysts.

  • Open: 158p
  • Range Today: 153/173p
  • 52 Week: 6.97/258p
  • Daily Volume: 3.0m
  • Daily Liquidity: (2.00%)
  • # Shares: 149.4m
  • Market Cap: £341.9m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
13Jan21 07:00 RNS First Patient Dosing in Phase III SG018 Trial
06Jan21 17:10 RNS Holding(s) in Company
05Jan21 17:53 RNS Holding(s) in Company
18Dec20 07:00 RNS COVID-19 Clinical Programme Update
10Dec20 12:57 RNS Holding(s) in Company
13Nov20 17:03 RNS Holding(s) in Company
13Nov20 07:00 RNS-R Lancet Respiratory Medicine publishes Phase 2 data
  • Frequency of research reports


  • Research reports on

    Synairgen plc

  • Providers covering

    Synairgen plc